Neratinib induces estrogen receptor function and sensitizes HER2-mutant breast cancer to anti-endocrine therapy Meeting Abstract

  

Authors:	Scaltriti, M.; Carmona, F. J.; Toska, E.; Cocco, E.; Hyman, D.; Cutler, R.; Avogadri-Connors, F.; Wick, M. J.; Papadopoulos, K. P.; Lalani, A. S.; Baselga, J.
Abstract Title:	Neratinib induces estrogen receptor function and sensitizes HER2-mutant breast cancer to anti-endocrine therapy
Meeting Title:	28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Journal Title:	European Journal of Cancer
Volume:	69
Issue:	Suppl. 1
Meeting Dates:	2016 Nov 29-Dec 2
Meeting Location:	Munich, Germany
ISSN:	0959-8049
Publisher:	Elsevier Inc.
Date Published:	2016-12-01
Start Page:	S125
Language:	English
ACCESSION:	WOS:000390503500366
PROVIDER:	wos
DOI:	10.1016/S0959-8049(16)32971-9
Notes:	Meeting Abstract: 378 -- 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 29-DEC 02, 2016 -- Munich, GERMANY -- Source: Wos